Following were the notable penny stock buzzers in the previous session on high volume. Keep an eye on these stocks this week.
If you are interested in nanocap stocks here is one you should look into
Wearable Health Solutions (OTCMKTS:WHSI) is a manufacturer of next-generation, advanced technology personal medical alarms and safety alert devices. WHSI’s technology can provide a leading edge for the Company in our current cutting-edge technology-driven markets.
● Unique Opportunity
Only Publicly Traded Small-Cap Stock in the $7.4 Billion PERS Market
● Major Marketing Campaign Kickoff Imminent
WHSI is launching a worldwide marketing campaign to expand its international network of distributors. Production is underway for the company’s spots on the weekly ‘Worldwide Business With kathy ireland®” show.
Ireland’s Company Reaches Over 200+ Million Households broadcast on FOX Business Network, Bloomberg International Television and video streams on all major social media platforms.
● iMax 4G Release
WHSI’s iHelp MAX™ 4G device is reportedly launching this year. The device will do more than transmit an emergency alarm for the user. It will also send medical personnel vital signs, such as heart rate.
This next-generation release would be huge for WHSI stock.
● WHSI Up Listing
WHSI’s Mark Cayle recently commented after releasing its Form 10, “Once our Form 10 Registration Statement is effective, we will consider an up listing to a broader stock exchange which could expand our exposure to institutional investors, money managers, family office funds, broker dealers, and other investors which is an important milestone in our corporate progression,” he concluded
An uplisting would be a major catalytic event.
American Battery Technology Company (OTCMKTS:ABML) stock was one of the notable active movers in previous trading session as the stock fell 5% at $1.22 with over 3.13 million shares traded hands, compared to its average volume of 2.68 million shares.
American Battery Technology Company engages in the exploration, mining, extraction, and recycling of battery metals. The company owns 644 placer mining claims on approximately 12,880 acres in the Western Nevada Basin, located in Railroad Valley in Nye County, Nevada.
Cyberlux Corporation (OTCMKTS:CYBL) stock continued to trend in a range on Monday. On Monday, the stock slid 16% to $0.0199 with more than 84.33 million shares traded hands, compared to its average volume of 42.46 million shares.
The company announced that the Company recorded $8,107,592 in Revenue and posted $1,903,766 in Net Income for the Full Year 2021. The Company also grew its Balance Sheet Assets to $9,327,043 with its successful platform acquisition strategy for the period ended December 31, 2021.
HUMBL Inc. (OTCMKTS:HMBL) stock was one of the most active stock buzzers. The stock moved up 10% at $0.1220 with over 11.69 million shares traded hands, compared to its average volume of 11.74 million shares.
The company announced that it has reduced its debt balance by exchanging promissory notes for common stock. On March 28, 2022, HUMBL entered into exchange agreements with various noteholders. Pursuant to such agreements, HUMBL exchanged promissory notes representing $3,176,804.61 in outstanding debt obligations for 37,374,172 shares of common stock.
Northwest Biotherapeutics Inc. (OTCMKTS:NWBO) stock was one of the notable active movers in previous trading session as the stock ended higher by 11% to $0.8751 with over 3.38 million shares traded hands, compared to its average volume of 1.43 million shares.
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Regen BioPharma Inc. (OTCMKTS:RGBP) stock was one of the most active stock buzzers. The stock slid 8.20% to $0.0090 with over 48.75 million shares traded hands, compared to its average volume of 30.55 million shares.
Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.
